v3.22.4
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common stock
Common stock in treasury
Additional contributed capital
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive income (loss)
Total Baxter stockholders' equity
Total Baxter stockholders' equity
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling interests
Beginning of year (in shares) at Dec. 31, 2019     683,000,000                
Beginning of year at Dec. 31, 2019 $ 7,912 $ (4) $ 683 $ (10,764) $ 5,955 $ 15,718 $ (4) $ (3,710) $ 7,882 $ (4) $ 30
Beginning of year (in shares) at Dec. 31, 2019       177,000,000              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) 1,110         1,102     1,102   8
Other comprehensive income (loss) $ 396             396 396    
Purchases of common stock (in shares) 6,300,000     6,000,000              
Purchases of treasury stock $ (500)     $ (500)         (500)    
Stock issued under employee benefit plans and other (in shares)       (4,000,000)              
Stock issued under employee benefit plans and other 301     $ 213 88       301    
Dividends declared on common stock (488)         (488)     (488)    
Other changes in noncontrolling interests (1)                   (1)
End of year (in shares) at Dec. 31, 2020     683,000,000                
End of year at Dec. 31, 2020 8,726   $ 683 $ (11,051) 6,043 16,328   (3,314) 8,689   37
End of year (in shares) at Dec. 31, 2020       179,000,000              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) 1,295         1,284     1,284   11
Other comprehensive income (loss) $ (66)             (66) (66)    
Purchases of common stock (in shares) 7,300,000     7,000,000              
Purchases of treasury stock $ (600)     $ (600)         (600)    
Stock issued under employee benefit plans and other (in shares)       (4,000,000)              
Stock issued under employee benefit plans and other 317     $ 163 154       317    
Dividends declared on common stock (547)         (547)     (547)    
Other changes in noncontrolling interests $ (4)                   (4)
End of year (in shares) at Dec. 31, 2021 683,494,944   683,000,000                
End of year at Dec. 31, 2021 $ 9,121   $ 683 $ (11,488) 6,197 17,065   (3,380) 9,077   44
End of year (in shares) at Dec. 31, 2021       182,000,000              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) (2,421)         (2,433)     (2,433)   12
Other comprehensive income (loss) $ (458)             (453) (453)   (5)
Purchases of common stock (in shares) 500,000                    
Purchases of treasury stock $ (32)     $ (32)         (32)    
Stock issued under employee benefit plans and other (in shares)       (3,000,000)              
Stock issued under employee benefit plans and other 256     $ 131 125       256    
Dividends declared on common stock (582)         (582)     (582)    
Other changes in noncontrolling interests $ 11                   11
End of year (in shares) at Dec. 31, 2022 683,494,944   683,000,000                
End of year at Dec. 31, 2022 $ 5,895   $ 683 $ (11,389) $ 6,322 $ 14,050   $ (3,833) $ 5,833   $ 62
End of year (in shares) at Dec. 31, 2022       179,000,000